In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus
about
Novel approaches and challenges to treatment of central nervous system viral infectionsBlockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirusInhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomersRecent Developments in Peptide-Based Nucleic Acid DeliveryProgress on the development of therapeutics against West Nile virusRecombination in West Nile Virus: minimal contribution to genomic diversityInhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in MiceBroad-spectrum agents for flaviviral infections: dengue, Zika and beyondFunctional Information Stored in the Conserved Structural RNA Domains of Flavivirus GenomesIdentification and characterization of inhibitors of West Nile virus.Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.Antiviral and neuroprotective role of octaguanidinium dendrimer-conjugated morpholino oligomers in Japanese encephalitis.Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.The mitochondrial import gene tomm22 is specifically required for hepatocyte survival and provides a liver regeneration model.Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus.Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.Co-selection of West Nile virus nucleotides that confer resistance to an antisense oligomer while maintaining long-distance RNA/RNA base pairings.Antiviral Phosphorodiamidate Morpholino Oligomers are Protective against Chikungunya Virus Infection on Cell-based and Murine ModelsDelivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies.Inhibition of norovirus replication by morpholino oligomers targeting the 5'-end of the genome.DNA mimics for the rapid identification of microorganisms by fluorescence in situ hybridization (FISH).Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infectionPotential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseasesWest Nile virus infection and immunity.A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus.Cell-Penetrating Peptides for Antiviral Drug Development.Splice-Switching Therapy for Spinal Muscular Atrophy.Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA.Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds.
P2860
Q26862449-5CD77AF1-889F-49E3-A568-2B7DC76B49C1Q27486045-F87E741E-F95A-48C7-9910-B9987E6B23C0Q27486413-79338CCC-C7CF-4C99-9C4F-1FBFD9B0C583Q27487857-1F8499CE-3AC0-4C3A-B12E-5CB46D22B4FBQ27489893-33DE5B5B-D928-413A-8A36-5B0A9C039679Q27490183-4060B104-203A-49D4-84D5-A8F05E932276Q27490424-EDFC4020-C9CB-4661-8822-684F46DCF214Q29994527-CD2498F7-01A2-45C8-A481-739A228653A8Q29994591-FB70CCFC-164B-4BC3-B4DB-034EB12E336BQ33462229-64C28560-C510-499F-B02A-B5E2D33DDCA8Q33570326-BDA41959-163D-4575-B5ED-D47D00706B5FQ33761035-B90794D5-B48E-431D-A541-FF761541CC41Q33857479-C74F92A4-7313-45A6-909D-36417FF39DB0Q33967786-6011EB99-E756-40B2-B7C2-DF49983B5EE1Q34787775-DFB0C81C-8D05-4B4F-85DD-4EE8FA098AD1Q35270489-4D2BF8C9-7CC6-43C8-8FCD-C83A7345E406Q35448745-94FD54F7-685B-47E7-8B50-C3749F970C35Q36292209-93BA518D-405A-42F2-9072-88A06EF0D35AQ36972120-ED5B4868-C66E-4AF9-91CB-012BBF3B3657Q36989997-B241D6D3-381A-4410-8FC5-2B8D959F71F3Q37083226-58519BBF-D1E0-4B44-93F1-03F5A78C571BQ37190830-719E53D4-55F7-4D19-964A-5297820D6431Q37819299-31442E4A-9E21-411A-8F1C-944778F504E1Q38074266-3AA0C0FF-076B-4CC3-A62A-F42953F693C5Q38898494-23B15BDB-A5E9-4BB1-BED9-273E46D5142BQ38974187-3C557AD4-20F1-4EAE-9180-12827EC84EA5Q39366631-F1B7F117-E00A-4BB6-9B72-1AF4E1BCE280Q39494864-4B1BD666-9840-4EEE-884A-A25F8C6A3A75Q42226373-734EE2A5-326D-4C9B-91CA-363126EBE9AAQ53687216-A40C4B06-EF6D-483F-B687-5A6AB343E8BA
P2860
In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
In vitro resistance selection ...... gomers against West Nile virus
@ast
In vitro resistance selection ...... gomers against West Nile virus
@en
In vitro resistance selection ...... gomers against West Nile virus
@nl
type
label
In vitro resistance selection ...... gomers against West Nile virus
@ast
In vitro resistance selection ...... gomers against West Nile virus
@en
In vitro resistance selection ...... gomers against West Nile virus
@nl
altLabel
In Vitro Resistance Selection ...... gomers against West Nile Virus
@en
prefLabel
In vitro resistance selection ...... gomers against West Nile virus
@ast
In vitro resistance selection ...... gomers against West Nile virus
@en
In vitro resistance selection ...... gomers against West Nile virus
@nl
P2093
P2860
P50
P356
P1476
In vitro resistance selection ...... gomers against West Nile virus
@en
P2093
Corey J Bennett
David A Stein
Mark Tilgner
Melissa J Behr
Patrick L Iversen
Susan A Jones
Tia S Deas
P2860
P304
P356
10.1128/AAC.00069-07
P407
P577
2007-07-01T00:00:00Z